Retinoic acid-induced differentiation increases the rate of oxygen consumption and enhances the spare respiratory capacity of mitochondria in SH-SY5Y cells

Mechanisms of Ageing and Development

Volumn 133, Issue 4, 2012, Pages 176-185

  Xun, Zhiyin ^a   Lee, Do Yup ^a   Lim, James ^a   Canaria, Christie A ^a   Barnebey, Adam ^a   Yanonne, Steven M ^a   McMurray, Cynthia T ^a,b  

^a LAWRENCE BERKELEY NATIONAL LABORATORY   (United States)

^b MAYO CLINIC   (United States)

Author keywords

Glycolysis; Neuroblastoma; Oxidative phosphorylation; Retinoic acid

Indexed keywords

RETINOIC ACID;

ACIDIFICATION; ARTICLE; BIOENERGY; CANCER CELL CULTURE; CELL DIFFERENTIATION; CELL METABOLISM; CELL RESPIRATION; CELL VIABILITY; CONFOCAL MICROSCOPY; CONTROLLED STUDY; ENERGY YIELD; GENE EXPRESSION REGULATION; GLYCOLYSIS; HUMAN; HUMAN CELL; MITOCHONDRIAL MEMBRANE POTENTIAL; MITOCHONDRIAL RESPIRATION; MORPHOLOGY; NEUROBLASTOMA; OXIDATIVE PHOSPHORYLATION; OXYGEN CONSUMPTION; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ANTINEOPLASTIC AGENTS; CELL DIFFERENTIATION; CELL LINE, TUMOR; CELL RESPIRATION; ELECTRON TRANSPORT CHAIN COMPLEX PROTEINS; ENERGY METABOLISM; GLYCOLYSIS; HUMANS; MITOCHONDRIA; NEUROBLASTOMA; NEURONS; OXIDATIVE PHOSPHORYLATION; OXYGEN CONSUMPTION; TIME FACTORS; TRETINOIN;

EID: 84862788524     PISSN: 00476374     EISSN: 18726216     Source Type: Journal    
DOI: 10.1016/j.mad.2012.01.008     Document Type: Article

References (57)

1. Ahn M.J., Langenfeld J., Moasser M.M., Rusch V., Dmitrovsky E. Growth suppression of transformed human bronchial epithelial cells by all-trans-retinoic acid occurs through specific retinoid receptors. Oncogene 1995, 11:2357-2364.
2. Cabrera-Valladares G., German M.S., Matschinsky F.M., Wang J., Fernandez-Mejia C. Effect of retinoic acid on glucokinase activity and gene expression and on insulin secretion in primary cultures of pancreatic islets. Endocrinology 1999, 140:3091-3096.
3. Cabrera-Valladares G., Matschinsky F.M., Wang J., Fernandez-Mejia C. Effect of retinoic acid on glucokinase activity and gene expression in neonatal and adult cultured hepatocytes. Life Sciences 2001, 68:2813-2824.
4. Chen K.-F., Chen H.-L., Tai W.-T., Feng W.-C., Hsu C.-H., Chen P.-J., Cheng A.-L. Activation of phosphatidylinositol 3-kinase/Akt signaling pathway mediates acquired resistance to sorafenib in hepatocellular carcinoma cells. Journal of Pharmacology and Experimental Therapeutics 2011, 337:155-161.
5. Cheung Y.T., Lau W.K., Yu M.S., Lai C.S., Yeung S.C., So K.F., Chang R.C. Effects of all-trans-retinoic acid on human SH-SY5Y neuroblastoma as in vitro model in neurotoxicity research. Neurotoxicology 2009, 30:127-135.
6. Ciccarone V., Spengler B.A., Meyers M.B., Biedler J.L., Ross R.A. Phenotypic diversification in human neuroblastoma cells: expression of distinct neural crest lineages. Cancer Research 1989, 49:219-225.
7. Davis C.W., Hawkins B.J., Ramasamy S., Irrinki K.M., Cameron B.A., Islam K., Daswani V.P., Doonan P.J., Manevich Y., Madesh M. Nitration of the mitochondrial complex I subunit NDUFB8 elicits RIP1- and RIP3-mediated necrosis. Free Radical Biology and Medicine 2010, 48:306-317.
8. De Luca L.M., Hansen L.A., Sigman C.C., Andreola F., Ross S.A., Kelloff G.J. Retinoids in chemoprevention and differentiation therapy. Carcinogenesis 2000, 21:1271-1279.
9. Deshmukh M., Kuida K., Johnson E.M. Caspase inhibition extends the commitment to neuronal death beyond cytochrome c release to the point of mitochondrial depolarization. Journal of Cell Biology 2000, 150:131-143.
10. Dranka B.P., Hill B.G., Darley-Usmar V.M. Mitochondrial reserve capacity in endothelial cells: the impact of nitric oxide and reactive oxygen species. Free Radical Biology and Medicine 2010, 48:905-914.
11. Duester G. Retinoic acid synthesis and signaling during early organogenesis. Cell 2008, 134:921-931.
12. El-Metwally T.H., Hameed D.A. The effectiveness of retinoic acid treatment in bladder cancer - impact on recurrence, survival and TGF alpha and VEGF as end-point biomarkers. Cancer Biology and Therapy 2008, 7:92-100.
13. Encinas M., Iglesias M., Liu Y., Wang H., Muhaisen A., Cena V., Gallego C., Comella J.X. Sequential treatment of SH-SY5Y cells with retinoic acid and brain-derived neurotrophic factor gives rise to fully differentiated, neurotrophic factor-dependent, human neuron-like cells. Journal of Neurochemistry 2000, 75:991-1003.
14. Everts H.B., Berdanier C.D. Regulation of mitochondrial gene expression by retinoids. IUBMB Life 2002, 54:45-49.
15. Fernandez-Mejia C., Davidson M.B. Regulation of glucokinase and proinsulin gene expression and insulin secretion in RIN-m5F cells by dexamethasone, retinoic acid, and thyroid hormone. Endocrinology 1992, 130:1660-1668.
16. Finklestein J.Z., Krailo M.D., Lenarsky C., Ladisch S., Blair G.K., Reynolds C.P., Sitarz A.L., Hammond G.D. 13-cis-retinoic acid (NSC 122758) in the treatment of children with metastatic neuroblastoma unresponsive to conventional chemotherapy: report from the Childrens Cancer Study Group. Medical and Pediatric Oncology 1992, 20:307-311.
17. Freemantle S.J., Spinella M.J., Dmitrovsky E. Retinoids in cancer therapy and chemoprevention: promise meets resistance. Oncogene 2003, 22:7305-7315.
18. Gleason C., Huang S., Thatcher L.F., Foley R.C., Anderson C.R., Carroll A.J., Millar A.H., Singh K.B. Mitochondrial complex II has a key role in mitochondrial-derived reactive oxygen species influence on plant stress gene regulation and defense. Proceedings of the National Academy of Sciences of the United States of America 2011, 108:10768-11077.
19. Hansen L.A., Sigman C.C., Andreola F., Ross S.A., Kelloff G.J., De Luca L.M. Retinoids in chemoprevention and differentiation therapy. Carcinogenesis 2000, 21:1271-1279.
20. Hogarty M.D. The requirement for evasion of programmed cell death in neuroblastomas with MYCN amplification. Cancer Letter 2003, 197:173-179.
21. Howard A.D., Verghese P.B., Arrese E.L., Soulages J.L. The beta-subunit of ATP synthase is involved in cellular uptake and resecretion of apoA-I but does not control apoA-I-induced lipid efflux in adipocytes. Molecular and Cellular Biochemistry 2011, 348:155-164.
22. Hsieh R.H., Lin Y.W., Lien L.M., Yeh T.S., Wu H.M., Liu Y.L. 9- cis retinoic acid induces retinoid X receptor localized to the mitochondria for mediation of mitochondrial transcription. Biochemical and Biophysical Research Communications 2008, 377:351-354.
23. Hu L.S., Xie H.R., Li G.Y. SH-SY5Y human neuroblastoma cell line: in vitro cell model of dopaminergic neurons in Parkinson's disease. Chinese Medical Journal 2010, 123:1086-1092.
24. Huang X., Eriksson K.F., Vaag A., Lehtovirta M., Hansson M., Laurila E., Kanninen T., Olesen B.T., Kurucz I., Koranyi L., Groop L. Insulin-regulated mitochondrial gene expression is associated with glucose flux in human skeletal muscle. Diabetes 1999, 48:1508-1514.
25. Jayaraman S. Flow cytometric determination of mitochondrial membrane potential changes during apoptosis of T lymphocytic and pancreatic beta cell lines: comparison of tetramethylrhodamineethylester (TMRE), chloromethyl-X-rosamine (H2-CMX-Ros) and MitoTracker Red 580 (MTR580). Journal of Immunological Methods 2005, 306:68-79.
26. Kalemkerian G.P., Jiroutek M., Ettinger D.S., Dorighi J.A., Johnson D.H., Mabry M. A phase II study of all-trans-retinoic acid plus cisplatin and etoposide in patients with extensive stage small cell lung carcinoma: an Eastern Cooperative Oncology Group Study. Cancer 1998, 83:1102-1108.
27. Kaur G., Singh J. Transcriptional regulation of polysialylated neural cell adhesion molecule expression by NMDA receptor activation in retinoic acid-differentiated SH-SY5Y neuroblastoma cultures. Brain Research 2007, 1154:8-21.
28. Levi M.S., Borne R.F., Williamson J.S. A review of cancer chemopreventive agents. Current Medicinal Chemistry 2001, 8:1349-1362.
29. Mandili G., Marini C., Carta F., Zanini C., Prato M., Khadjavi A., Turrini F., Giribaldi G. Identification of phosphoproteins as possible differentiation markers in all-trans-retinoic acid-treated neuroblastoma cells. PLoS One 2011, 6:e18254.
30. Mankoo B.S., Reijntjes S., Francis-West P. Retinoic acid is both necessary for and inhibits myogenic commitment and differentiation in the chick limb. International Journal of Developmental Biology 2010, 54:125-134.
31. Matthay K.K., Reynolds C.P., Seeger R.C., Shimada H., Adkins E.S., Haas-Kogan D., Gerbing R.B., London W.B., Villablanca J.G. Long-term results for children with high-risk neuroblastoma treated on a randomized trial of myeloablative therapy followed by 13-cis-retinoic acid: a children's oncology group study. Journal of Clinical Oncology 2009, 27:1007-1013.
32. Matthay K.K., Villablanca J.G., Seeger R.C., Stram D.O., Harris R.E., Ramsay N.K., Swift P., Shimada H., Black C.T., Brodeur G.M., Gerbing R.B., Reynolds C.P. Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. Children's Cancer Group. New England Journal of Medicine 1999, 341:1165-1173.
33. Messi E., Florian M.C., Caccia C., Zanisi M., Maggi R. Retinoic acid reduces human neuroblastoma cell migration and invasiveness: effects on DCX, LISI, neurofilaments-68 and vimentin expression. BMC Cancer 2008, 8.
34. Motzer R.J., Murphy B.A., Bacik J., Schwartz L.H., Nanus D.M., Mariani T., Loehrer P., Wilding G., Fairclough D.L., Cella D., Mazumdar M. Phase III trial of interferon alfa-2a with or without 13-cis-retinoic acid for patients with advanced renal cell carcinoma. Journal of Clinical Oncology 2000, 18:2972-2980.
35. Naithani R., Huma L.C., Moriarty R.M., McCormick D.L., Mehta R.G. Comprehensive review of cancer chemopreventive agents evaluated in experimental carcinogenesis models and clinical trials. Current Medicinal Chemistry 2008, 15:1044-1071.
36. Napoli J.L. Interactions of retinoid binding proteins and enzymes in retinoid metabolism. Biochimica et Biophysica Acta 1999, 1440:139-162.
37. Oh-hashi K., Maruyama W., Yi H., Takahashi T., Naoi M., Isobe K. Mitogen-activated protein kinase pathway mediates peroxynitrite-induced apoptosis in human dopaminergic neuroblastoma SH-SY5Y cells. Biochemical and Biophysical Research Communications 1999, 263:504-509.
38. Pang L., Qiu T., Cao X., Wan M. Apoptotic role of TGF-beta mediated by Smad4 mitochondria translocation and cytochrome c oxidase subunit II interaction. Experimental Cell Research 2011, 317:1608-1620.
39. Perez J., Hill B.G., Benavides G.A., Dranka B.P., Darley-Usmar V.M. Role of cellular bioenergetics in smooth muscle cell proliferation induced by platelet-derived growth factor. Biochemical Journal 2010, 428:255-267.
40. Preis P.N., Saya H., Nádasdi L., Hochhaus G., Levin V., Sadée W. Neuronal cell differentiation of human neuroblastoma cells by retinoic acid plus herbimycin A. Cancer Research 1988, 48:6530-6534.
41. Reynolds C.P., Kane D.J., Einhorn P.A., Matthay K.K., Crouse V.L., Wilbur J.R., Shurin S.B., Seeger R.C. Response of neuroblastoma to retinoic acid in vitro and in vivo. Progress in Clinical and Biological Research 1991, 366:203-211.
42. Reynolds C.P., Wang Y., Melton L.J., Einhorn P.A., Slamon D.J., Maurer B.J. Retinoic-acid-resistant neuroblastoma cell lines show altered MYC regulation and high sensitivity to fenretinide. Medical and Pediatric Oncology 2000, 35:597-602.
43. Ross R., Spengler B., Domenech C., Porubcin M., Rettig W., Biedler J. Human neuroblastoma I-type cells are malignant neural crest stem cells. Cell Growth and Differentiation 1995, 6:449-456.
44. Ruff S.J., Ong D.E. Cellular retinoic acid binding protein is associated with mitochondria. FEBS Letters 2000, 487:282-286.
45. Sansbury B.E., Jones S.P., Riggs D.W., Darley-Usmar V.M., Hill B.G. Bioenergetic function in cardiovascular cells: the importance of the reserve capacity and its biological regulation. Chemistry and Biology Interaction 2011, 191:288-295.
46. Sanz M.A., Montesinos P., Rayon C., Holowiecka A., de la Serna J., Milone G., de Lisa E., Brunet S., Rubio V., Ribera J.M., Rivas C., Krsnik I., Bergua J., Gonzalez J., Diaz-Mediavilla J., Rojas R., Manso F., Ossenkoppele G., Gonzalez J.D., Lowenberg B. Risk-adapted treatment of acute promyelocytic leukemia based on all-trans retinoic acid and anthracycline with addition of cytarabine in consolidation therapy for high-risk patients: further improvements in treatment outcome. Blood 2010, 115:5137-5146.
47. Soprano D.R., Ravikumar S., Perez-Liz G., Del Vale L., Soprano K.J. Insulin receptor substrate-1 is an important mediator of ovarian cancer cell growth suppression by all-trans retinoic acid. Cancer Research 2007, 67:9266-9275.
48. Stowe D.F., Camara A.K. Mitochondrial reactive oxygen species production in excitable cells: modulators of mitochondrial and cell function. Antioxidation Redox Signaling 2009, 11:1373-1414.
49. Suthammarak W., Morgan P.G., Sedensky M.M. Mutations in mitochondrial complex III uniquely affect complex I in Caenorhabditis elegans. Journal of Biological Chemistry 2010, 285:40724-40731.
50. Syed Z., Cheepala S.B., Gill J.N., Stein J., Nathan C., Digiovanni J., Batra V., Adegboyega P., Kleiner H.E., Clifford J.L. All-trans retinoic acid suppresses Stat3 signaling during skin carcinogenesis. Cancer Prevention Research 2009, 2:903-911.
51. Tosetti P., Taglietti V., Toselli M. Functional changes in potassium conductances of the human neuroblastoma cell line SH-SY5Y during in vitro differentiation. Journal of Neurophysiology 1998, 79:648-658.
52. Truckenmiller M.E., Marquis P.V., Chris C., Mark C., David M.D., William J.F., Kevin G.B. Gene expression profile in early stage of retinoic acid-induced differentiation of human SH-SY5Y neuroblastoma cells. Restorative Neurology and Neuroscience 2001, 18:67-80.
53. Voet D., Voet J.G., Pratt C.W. Fundamentals of Biochemistry 2006, John Wiley and Sons Inc. 2nd edition.
54. Wang C.X., Song J.H., Song D.K., Yong V.W., Shuaib A., Hao C. Cyclin-dependent kinase-5 prevents neuronal apoptosis through ERK-mediated upregulation of Bcl-2. Cell Death and Differentiation 2006, 13:1203-1212.
55. Wu M., Neilson A., Swift A.L., Moran R., Tamagnine J., Parslow D., Armistead S., Lemire K., Orrell J., Teich J., Chomicz S., Ferrick D.A. Multiparameter metabolic analysis reveals a close link between attenuated mitochondrial bioenergetic function and enhanced glycolysis dependency in human tumor cells. American Journal of Physiology-Cell Physiology 2007, 292:C125-C136.
56. Yadava N., Nicholls D.G. Spare respiratory capacity rather than oxidative stress regulates glutamate excitotoxicity after partial respiratory inhibition of mitochondrial complex I with rotenone. Journal of Neuroscience 2007, 27:7310-7317.
57. Zhang C., Duvic M. Treatment of cutaneous T-cell lymphoma with retinoids. Dermatology Theraphy 2006, 19:264-271.